跳至主要内容
临床试验/NCT04889352
NCT04889352已完成不适用

Optimizing Timing of Follow-up Colonoscopy: A Pilot Cluster Randomized Trial to Test the Utility of a Knowledge Translation Tool

University of Manitoba2 个研究点 分布在 1 个国家目标入组 29 人开始时间: 2021年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
29
试验地点
2
主要终点
Proportion of cases where the colonoscopy physician recommendations matched with the guideline recommendation

研究概览

简要总结

Overall Objective: To optimize timing of surveillance colonoscopy.

Principal research question and specific aims: To assess the impact of access to a hand-held application on the timing of surveillance colonoscopy. To assess whether access to the tool improves adherence to recommended guidelines for follow-up colonoscopy intervals.

Colonoscopy is commonly used for surveillance of patients with high risk of developing colorectal cancer, including those with family history of colorectal cancer and those with colorectal polyps. The recommended timing of surveillance colonoscopy varies by the estimated risk for development of colorectal cancer. The estimated risk varies by family history of colorectal cancer (number of affected individuals, age of the persons affected with CRC) and characteristics of the colorectal polyps (size, number, and histology of colorectal polyps (tubular or villous; high grade or low-grade dysplasia; sessile serrated polyp, sessile serrated polyp with dysplasia, hyperplastic polyp or traditional serrated adenomas). Guidelines take all of these factors into account in the recommendations for follow-up colonoscopy and hence are difficult to recall for the busy clinicians. Colonoscopy surveillance is frequently performed at shorter or longer than the recommended time intervals. The investigators have developed a smart phone application in which the characteristics of the patients can be inputted and the tool provides the recommended time interval for surveillance colonoscopy, based on North American guidelines. The investigators are proposing a pilot randomized trial to determine sample size estimates for a larger trial to assess the utility of this application in clinical practice.

详细描述

Study design and intervention: This will be a cluster randomized controlled trial in which individual endoscopy physicians (gastroenterologists and surgeons) will be randomized (stratified by physician specialty) to one of two groups: A) provided access to the application (intervention group) or B) not provided access to the application (control group). In the intervention group, the application can be downloaded to smart phones for portability which will allow access in an endoscopy suite or in clinic or used as a reference at other times. It can also be accessed online (all endoscopy rooms in Winnipeg have computers with internet access for the endoscopy physicians' use). The clusters of patients will be defined by the endoscopy physician providing the colonoscopy.

Intervention: Access to the application which will be available both as a web-based as well as a smart phone application.

Setting: Colonoscopies included in the study will be those performed in the Winnipeg endoscopy units.

A research assistant will extract data from medical records maintained by the hospitals and physicians privately. Individual cases of colonoscopies will be identified through the city-wide endoscopy program database. Study data will be collected and managed using the REDCap (Research Electronic Data Capture) electronic data capture tools hosted at the University of Manitoba.

Concealment of Allocation and Randomization: Randomization will be performed after the endoscopy physician consent and enrollment into the study. A computer generated randomization sequence will used in blocks of eight. Stratification for surgical and gastroenterology endoscopy physician will be performed as there might be differential adherence to recommendations by speciality of training.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Investigator)

盲法说明

Randomization will be performed after the endoscopy physician consent and enrolment into the study. A computer generated randomization sequence will used in blocks of eight. Stratification for surgical and gastroenterology endoscopy physician will be performed as there might be differential adherence to recommendations by specialty of training.Randomization will be performed and the application distributed by study personnel different than those involved in data extraction from medical records so that the person extracting the data remains blinded to the randomized group assignment. Patients of participating physicians will not require blinding as they will not be approached by the study investigators and will get routine care decided by their physicians.

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •For physician participants, there are no age limits/parameters. All physicians performing colonoscopy on adult patients in Winnipeg will be eligible to participate (other than those involved in pilot testing and study investigators). Participating physicians will be informed that the introduced intervention will be an information tool to help improve care for individuals undergoing colonoscopy, and will be asked to consent to review of their patient records. Participating physicians will be informed that no individual-level information will be disclosed at any time and all analysis will be on anonymized data.
  • •For patient participants:
  • •Patients must be older than 50 years and up to 75 years old for inclusion in the study data.
  • •Adequate bowel preparation defined by Boston Bowel Preparation Scale Score of ≥ 2 in each of segments of the colon (Boston bowel prep scale score recording is mandatory in the Winnipeg city-wide endoscopy reporting system);
  • •Colonoscopy completed to the cecum/ileocolonic anastomosis;
  • •Colonoscopy performed between 1 to 4 months before randomization of endoscopy physician (to determine baseline adherence) or between 3 to 7 months after randomization (to determine effect of the intervention).

排除标准

  • •Physicians will be excluded if they are away for more than six weeks continuously in the six months after randomization. In this situation, an alternate physician will be recruited and randomized. Thus there is no anticipated loss of follow-up.
  • •Patients will be excluded if any of the following criteria are met:
  • •History of inherited CRC predisposition (Lynch Syndrome, Familial adenomatous polyposis, others);
  • •Inflammatory bowel disease;
  • •Partially excised polyp or endoscopy physician recommending early colonoscopy to document complete excision;
  • •Endoscopy physician documenting a rationale for not repeating colonoscopy in future such as co-morbid conditions.

研究组 & 干预措施

Access to colonoscopy web app

Experimental

Approximately half of the consenting individual endoscopy physicians in the city (gastroenterologists and surgeons) will be randomized (stratified by physician specialty) to the intervention group where they are provided access to an application which indicates recommended timing of follow-up colonoscopy given values for various entered factors. In the intervention group, the application can be downloaded to smart phones for portability which will allow access in an endoscopy suite or in clinic or used as a reference at other times. It can also be accessed online (all endoscopy rooms in Winnipeg have computers with internet access for the endoscopy physicians' use). Access to the application will be password-protected, thereby avoiding exposure of the non-intervention group to the application. The clusters of patients will be defined by the endoscopy physician providing the colonoscopy.

干预措施: Access to colonoscopy web app (Other)

Control

No Intervention

Approximately half of the consenting individual endoscopy physicians in the city (gastroenterologists and surgeons) will be randomized (stratified by physician specialty) to the group where they are not provided access to the application (control group).

结局指标

主要结局

Proportion of cases where the colonoscopy physician recommendations matched with the guideline recommendation

时间窗: 7 months

% of patients whose recommended colonoscopy frequency is in agreement with guideline recommendation based on patient factors and colonoscopy findings'

次要结局

  • Physicians' use of the application (how often used)(7 months)
  • Physicians' use of the application (how often used during endoscopy slate)(7 months)
  • Physicians' use of the application (main reason provided, among those neutral or unlikely to use on ongoing basis)(7 months)
  • Physicians' use of the application (ease of use)(7 months)
  • Physicians' use of the application (how often used during non-endoscopy clinical days)(7 months)
  • Physicians' use of the application (likelihood of using tool on ongoing basis in practice)(7 months)
  • Physicians' use of the application (tool reliable)(7 months)
  • Proportion of cases which have a documented recommendation(7 months)
  • Physicians' use of the application (how familiar is the information in the tool)(7 months)
  • Physicians' use of the application (how often used in first month)(7 months)
  • Physicians' use of the application (impact upon decisions)(7 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Unknown
4 期
Impact of Time Intervals of Preparation on Quality and Tolerance of the Bowel PreparationColonoscopyBowel Preparation
NCT02908919Faculty Hospital Kralovske Vinohrady480
已完成
不适用
Side Specific Withdrawal Times for Colonoscopy: Impact on Adenoma Detection in the Proximal and Distal ColonColon Adenoma
NCT02819492Technical University of Munich500
进行中(未招募)
1 期
Which bowel preparation regime gives the most optimal Colon Capsule Endocscopy in patients with high risk polyps.Endoscopic examination of the colon and rectum for polyps and cancersMedDRA version: 19.0Level: LLTClassification code 10010026Term: Colorectal cancer Duke's ASystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010027Term: Colorectal cancer Duke's CSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010028Term: Colorectal cancer Duke's DSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010029Term: Colorectal cancer NOSSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010024Term: Colorectal cancer Duke's B1System Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010025Term: Colorectal cancer Duke's B2System Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10052362Term: Metastatic colorectal cancerSystem Organ Class: 100000004864MedDRA version: 19.0Level: LLTClassification code 10010031Term: Colorectal cancer stage B2System Organ Class: 100000004864
EUCTR2016-002237-30-DKOdense University Hospital180
已完成
不适用
Minimizing Peri-operative Time Delays, Maximizing Operating Room Efficiency: A Pilot StudyOperating Room Efficiency
NCT03257384Unity Health Toronto25
已完成
不适用
Comparison of Adenoma Detection Miss Rates at Colonoscopy Associated With Different Withdrawal TimesAdenoma and/or AdenocarcinomaAdenoma
NCT01802008Stanford University200